- €2.43bn
- €3.67bn
- €2.64bn
Brief: Synlab Says Cybersecurity Incident At Synnovis In UK
Diagnostics provider Synlab signs delisting agreement with Ephios
Brief: Ephios Bidco To Make Public Delisting Acquisition Offer To Shareholders Of Synlab
Brief: Synlab Continues To Expect AEBITDA Margin To Improve From Its Low Point in 2023
Brief: SYNLAB Q1 Revenue EUR 682.4 Million
Brief: Synlab Italy Restores Operations After Cyber-attack
Brief: Synlab Affected By Cyber-Attack In Italy
Brief: Synlab AG Entered Into A Loan Agreement Of EUR 535 Mln
Brief: Synlab Expects AEBITDA Margin To Be Within Range Of 17-18% In 2024
Brief: SYNLAB FY Revenue EUR 2,635.2 Million
Private equity double-dips are a tasty faux pas
Brief: SYNLAB 9M Revenue EUR 1,989.9 Million
Brief: Synlab 9-month Net Profit Down At EUR 169 Million
Brief: Synlab Publishes Joint Statement On Cinven Offer
Brief: Cinven Launches Public Acquisition Offer For Synlab
RCS - SYNLAB International - SYNLAB launches: myEDIT-B
Brief: Synlab Launches Revolutionary Bipolar Disorder Diagnostic Test Myedit-B
HSBC prefers Biomerieux as healthcare equipment sector struggles with COVID unwind
Covid tester buyout hands investors a bitter pill